http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100400509-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1996-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100400509-B1 |
| titleOfInvention | Pharmaceuticals containing methotrexate derivatives |
| abstract | The compound represented by the formula (I) below or a salt thereof is useful as a therapeutic agent for autoimmune diseases (e.g., systemic lupus erythematosus) or nephritis (e.g., glomerulonephritis).n n n (I)n n n n n n n n (Wherein,n n n R 1 represents one selected from the group consisting of CH 2 , CH 2 CH 2 , CH 2 O, CH 2 S and CH 2 SO,n n n R 2 represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms or a benzyl group,n n n R 3 represents a group represented by the general formula COOR 4 , the general formula NHCOR 5 , or the general formula CONR 6 R 7 , or PO 3 H 2 or SO 3 H,n n n and n represents an integer of 1 to 4). |
| priorityDate | 1995-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.